These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1465035)

  • 1. Effect of 17 beta-oestradiol and norethisterone acetate on vertebral bone mass and lipid metabolism in early postmenopausal women.
    Ribot C; Tremollieres F; Pouilles JM
    Maturitas; 1992 Dec; 15(3):217-23. PubMed ID: 1465035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate.
    Lindgren R; Berg G; Hammar M; Larsson-Cohn U; Olsson AG
    Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):213-21. PubMed ID: 1294408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
    Christiansen C; Riis BJ
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment.
    Pors Nielsen S; Bärenholdt O; Hermansen F; Munk-Jensen N
    Br J Obstet Gynaecol; 1994 Apr; 101(4):319-24. PubMed ID: 8199078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
    Stevenson JC; Cust MP; Gangar KF; Hillard TC; Lees B; Whitehead MI
    Lancet; 1990 Aug; 336(8710):265-9. PubMed ID: 1973969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
    Mueck AO; Seeger H; Lippert TH
    Clin Exp Obstet Gynecol; 1998; 25(1-2):26-8. PubMed ID: 9841134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J; Hammar M
    Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E; Mälkönen M; Manninen V
    N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
    Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent.
    Bjarnason NH; Alexandersen P; Christiansen C
    Bone; 2002 Apr; 30(4):637-42. PubMed ID: 11934658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.
    Alexandersen P; Riis BJ; Stakkestad JA; Delmas PD; Christiansen C
    J Clin Endocrinol Metab; 2001 Feb; 86(2):755-60. PubMed ID: 11158042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transdermal regimen for continuous combined hormone replacement therapy in the menopause.
    Keller PJ; Hotz E; Imthurn B
    Maturitas; 1992 Dec; 15(3):195-8. PubMed ID: 1465033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW; Gluck OS; Lang E; Rakov V
    Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects.
    Alexandersen P; Byrjalsen I; Christiansen C
    BJOG; 2000 Mar; 107(3):356-64. PubMed ID: 10740332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
    Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
    Goulding A; Gold E
    J Endocrinol; 1993 Apr; 137(1):27-33. PubMed ID: 8492074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
    Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
    Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.